 |
answer text |
<p>Pre-exposure prophylaxis (PrEP) is currently funded through the three-year PrEP
Impact Trial. Following my Rt. hon. Friend the Secretary of State for Health and Social
Care’s announcement on 30 January that the number of places on the trial would be
doubled to 26,000, expansion of the Trial is now underway across the country. A core
function of the PrEP Impact Trial Community Advisory Board (CAB) is to raise awareness
and uptake of PrEP in key populations including black, Asian and minority ethnic (BAME)
communities. Further information about PrEP Impact Trial CAB activities and participating
community groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/"
target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p><a
href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>In
addition, Public Health England’s Innovation Fund has supported a number of community
based projects aimed at increasing PrEP awareness in women, BAME groups and trans
communities. Information on the projects funded in 2018 can be found at the following
link:</p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018"
target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>
</p>
|
|
